Akebia Therapeutics (AKBA) Debt Ratio: 2018-2025
Historic Debt Ratio for Akebia Therapeutics (AKBA) over the last 6 years, with Sep 2025 value amounting to 0.13.
- Akebia Therapeutics' Debt Ratio fell 29.34% to 0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13, marking a year-over-year decrease of 29.34%. This contributed to the annual value of 0.18 for FY2024, which is 22.20% up from last year.
- Per Akebia Therapeutics' latest filing, its Debt Ratio stood at 0.13 for Q3 2025, which was down 3.93% from 0.14 recorded in Q2 2025.
- Akebia Therapeutics' 5-year Debt Ratio high stood at 0.19 for Q4 2022, and its period low was 0.13 during Q3 2025.
- For the 3-year period, Akebia Therapeutics' Debt Ratio averaged around 0.16, with its median value being 0.17 (2023).
- As far as peak fluctuations go, Akebia Therapeutics' Debt Ratio surged by 59.11% in 2021, and later fell by 29.34% in 2025.
- Akebia Therapeutics' Debt Ratio (Quarterly) stood at 0.18 in 2021, then rose by 0.71% to 0.19 in 2022, then declined by 22.68% to 0.14 in 2023, then increased by 22.20% to 0.18 in 2024, then declined by 29.34% to 0.13 in 2025.
- Its Debt Ratio was 0.13 in Q3 2025, compared to 0.14 in Q2 2025 and 0.15 in Q1 2025.